Application 021085
- Type
- NDA
- Sponsor
- BAYER HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | TABLET;ORAL | EQ 400MG BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021085-001 | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | AB | RLD, RS | 1999-12-10 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | AB | RLD, RS | 1999-12-10 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | AB | RLD, RS | 1999-12-10 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | AB | RLD, RS | 1999-12-10 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N021085-001 | AVELOX | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-12-10 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021085-001 | AVELOX | EQ 400MG BASE | TABLET / ORAL | RLD | 1999-12-10 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021085-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | N021085-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021085-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021085-001 | AB | 1 | ea99ee380514… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021085-001 | 6610327 | 2019-10-29 | U-298 | Drug product | 74a2ff9319b5… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021085-001 | 6610327 | 2019-10-29 | U-298 | Drug product | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021085-001 | 6610327 | 2019-10-29 | U-298 | Drug product | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021085-001 | 6610327 | 2019-10-29 | U-298 | Drug product | ea99ee380514… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021085-001 | M-185 | 2019-09-27 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | N021085-001 | M-185 | 2019-09-27 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021085-001 | M-185 | 2019-09-27 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021085-001 | M-185 | 2019-09-27 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | American Health Packaging | 1ed191f5-7df5-488c-bb72-91ac0b618d9a | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| MOXIFLOXACIN HYDROCHLORIDE | MOXIFLOXACIN HYDROCHLORIDE | REMEDYREPACK INC. | bd0c0690-ba48-41c5-b76b-b1a53c36f424 | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | Redpharm Drug | 51d45346-5506-d2c9-e063-6394a90ae6bb | 2026-05-15 | Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | AvPAK | 371ca7b2-c62d-ef4b-3076-890b385bfff8 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| MOXIFLOXACIN HYDROCHLORIDE | MOXIFLOXACIN HYDROCHLORIDE | Mylan Institutional LLC | c6fa4129-2f92-4179-ac5d-bb7b4a538789 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | be5b7a6f-9ee3-4453-807e-4761fffff60c | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| MOXIFLOXACIN HYDROCHLORIDE | MOXIFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 1a98b20d-c4a1-4184-8387-a4866d1d62bf | 2026-02-16 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| MOXIFLOXACIN HYDROCHLORIDE | MOXIFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 18b77b31-baf3-416f-b3b7-a631c8e46d20 | 2026-02-16 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| MOXIFLOXACIN HYDROCHLORIDE | MOXIFLOXACIN HYDROCHLORIDE | Bryant Ranch Prepack | 6cd420c3-113e-4fc2-b59f-bfc7c485c14d | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| VIGAMOX | MOXIFLOXACIN HYDROCHLORIDE | Harrow Eye, LLC | 12053b08-7e66-c6f3-e063-6394a90a9cd9 | 2026-01-22 | Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| MOXIFLOXACIN HYDROCHLORIDE | MOXIFLOXACIN HYDROCHLORIDE | Major Pharmaceuticals | 815d71cf-02de-4190-9bd1-3fdc67ef0f06 | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | Bryant Ranch Prepack | ac8a81b9-2fed-412a-8c83-db8dee1061f6 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | Rising Pharma Holdings, Inc. | f34c08e6-fe74-4de3-9e36-a82c3c1c183b | 2025-10-10 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | A-S Medication Solutions | 37466c79-8726-4fd6-9412-0bb83d523fe3 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin | MOXIFLOXACIN HYDROCHLORIDE | Solaris Pharma Corporation | 45ce14e5-98b8-296b-e063-6294a90a769b | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| MOXIFLOXACIN HYDROCHLORIDE | MOXIFLOXACIN HYDROCHLORIDE | Aurobindo Pharma Limited | d6789c17-4a2f-4519-9060-e3b0dba422f0 | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | REMEDYREPACK INC. | 54377276-96bf-4140-9e90-55623ab6b013 | 2025-08-27 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | Asclemed USA, Inc. | 8f92f110-32d6-4d0c-a415-7a9a4cafb9b8 | 2025-04-19 | Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | Somerset Therapeutics, LLC | f7c68d49-8c61-4bde-a880-4d78568e5aa0 | 2024-11-25 | Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
| MOXIFLOXACIN HYDROCHLORIDE | MOXIFLOXACIN HYDROCHLORIDE | A-S Medication Solutions | 02c29e8e-8346-4e28-b7fc-2f4cb61ad37d | 2024-09-18 | Boxed warning, Warnings, Adverse reactions | MOXIFLOXACIN HYDROCHLORIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0085-1733 | Avelox | moxifloxacin hydrochloride | Schering Plough Corporation | NDA | Current |
| 43063-580 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride | PD-Rx Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 43063-580 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride | PD-Rx Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 43063-580 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride | PD-Rx Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 43063-585 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride | PD-Rx Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 47781-268 | Moxifloxacin Hydrochloride | moxifloxacin hydrochloride | Alvogen, Inc. | NDA AUTHORIZED GENERIC | Current |
| 50419-530 | Avelox | moxifloxacin hydrochloride | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-530 | Avelox | moxifloxacin hydrochloride | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 67296-0154 | Avelox | moxifloxacin hydrochloride | RedPharm Drug Inc. | NDA | Current |
| 67296-1299 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride | RedPharm Drug, Inc. | NDA AUTHORIZED GENERIC | Current |
| 67296-1299 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride | RedPharm Drug, Inc. | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82858 | SUPPL | 2025-07-14 |
| 82857 | SUPPL | 2025-07-14 |
| 82826 | SUPPL | 2025-07-14 |
| 62848 | SUPPL | 2020-05-07 |
| 62844 | SUPPL | 2020-05-07 |
| 62847 | SUPPL | 2020-05-06 |
| 58619 | SUPPL | 2019-05-08 |
| 58618 | SUPPL | 2019-05-08 |
| 58571 | SUPPL | 2019-05-06 |
| 56066 | SUPPL | 2018-10-23 |
| 56033 | SUPPL | 2018-10-19 |
| 45433 | SUPPL | 2016-09-30 |
| 45432 | SUPPL | 2016-09-30 |
| 45431 | SUPPL | 2016-09-30 |
| 45430 | SUPPL | 2016-09-30 |
| 26716 | SUPPL | 2016-07-26 |
| 14348 | SUPPL | 2016-07-26 |
| 36079 | SUPPL | 2015-06-05 |
| 26715 | SUPPL | 2015-05-13 |
| 36078 | SUPPL | 2014-12-03 |
| 26714 | SUPPL | 2014-11-24 |
| 26713 | SUPPL | 2013-08-16 |
| 14347 | SUPPL | 2013-08-15 |
| 26712 | SUPPL | 2012-12-26 |
| 36077 | SUPPL | 2012-12-21 |
| 36076 | SUPPL | 2012-09-11 |
| 4282 | SUPPL | 2012-08-28 |
| 26711 | SUPPL | 2011-10-20 |
| 14346 | SUPPL | 2011-10-20 |
| 14345 | SUPPL | 2011-10-20 |
| 4281 | SUPPL | 2011-10-20 |
| 26710 | SUPPL | 2011-08-08 |
| 36075 | SUPPL | 2011-03-04 |
| 4280 | SUPPL | 2011-03-02 |
| 4278 | SUPPL | 2010-11-02 |
| 14343 | SUPPL | 2010-10-25 |
| 4279 | SUPPL | 2010-04-09 |
| 36074 | SUPPL | 2010-03-05 |
| 26709 | SUPPL | 2010-01-25 |
| 14344 | SUPPL | 2009-12-02 |
| 4277 | SUPPL | 2009-06-29 |
| 14342 | SUPPL | 2009-05-15 |
| 26708 | SUPPL | 2009-05-05 |
| 36072 | SUPPL | 2009-01-02 |
| 26707 | SUPPL | 2008-12-31 |
| 36073 | SUPPL | 2008-10-09 |
| 4276 | SUPPL | 2008-10-07 |
| 14341 | SUPPL | 2008-02-25 |
| 4275 | SUPPL | 2008-02-20 |
| 21432 | SUPPL | 2008-02-19 |
| 36071 | SUPPL | 2007-06-04 |
| 4274 | SUPPL | 2007-06-04 |
| 14340 | SUPPL | 2005-11-30 |
| 14339 | SUPPL | 2005-11-30 |
| 4273 | SUPPL | 2005-11-30 |
| 4272 | SUPPL | 2005-11-30 |
| 36070 | SUPPL | 2005-06-14 |
| 4271 | SUPPL | 2005-06-14 |
| 14338 | SUPPL | 2004-07-30 |
| 4270 | SUPPL | 2004-07-30 |
| 41939 | ORIG | 2004-05-27 |
| 21431 | SUPPL | 2004-05-27 |
| 14336 | SUPPL | 2004-05-27 |
| 4268 | SUPPL | 2004-05-26 |
| 14337 | SUPPL | 2004-04-05 |
| 4269 | SUPPL | 2004-03-10 |
| 36069 | SUPPL | 2003-10-10 |
| 26706 | SUPPL | 2003-10-06 |
| 26705 | SUPPL | 2003-03-10 |
| 26704 | SUPPL | 2003-03-10 |
| 4267 | SUPPL | 2003-03-10 |
| 36068 | SUPPL | 2003-02-28 |
| 36067 | SUPPL | 2003-02-28 |
| 14335 | SUPPL | 2003-02-28 |
| 36064 | SUPPL | 2002-06-12 |
| 36063 | SUPPL | 2002-06-12 |
| 26701 | SUPPL | 2002-06-12 |
| 4266 | SUPPL | 2002-06-12 |
| 36066 | SUPPL | 2002-05-16 |
| 26703 | SUPPL | 2002-05-16 |
| 36065 | SUPPL | 2001-04-27 |
| 26702 | SUPPL | 2001-04-27 |
| 36062 | ORIG | 1999-12-10 |
| 26700 | ORIG | 1999-12-10 |
| 51387 | ORIG | 1900-01-01 |
| 51386 | ORIG | 1900-01-01 |
| 51385 | ORIG | 1900-01-01 |